| |
HAART +AAP (n=27) |
HAART alone (n=40) |
AAP alone (n=40) |
| Mean Change in Glucose ± SD
(mg/dL) |
+2.2 ± 41.0 |
-3.6 ± 38.5 |
+1.1 ± 50.3 |
| Mean Change in BMI ± SD
(kg/m2) |
+0.8 ± 4.9* |
+0.5 ± 6.3 |
+0.9 ± 5.8 |
New Development of Metabolic
Syndrome, no. (%) |
2 (7) |
0 (0) |
11 (27.5) |
| Diabetes Meds Added/
Changed, no. (%) |
2 (7) |
7 (14.5) |
12 (30) |
| Lipid Meds Added/Changed,
no. (%) |
13 (48) |
14 (35) |
17 (42.5) |
| Total Meds Added/Changed,
no. (%) |
15 (55.5) |
21 (52.5) |
29 (72.5) |
HAART: highly active antiretroviral therapy; AAP: atypical antipsychotic; BMI: